SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-080793
Filing Date
2022-07-19
Accepted
2022-07-19 13:23:27
Documents
2
Period of Report
2022-07-15

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2221312-5_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2221312-5_4seq1.xml 4 4418
2 EXHIBIT 24 tm2221312d5_ex24.htm EX-24 7247
  Complete submission text file 0001104659-22-080793.txt   13038
Mailing Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169
Business Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169 212-847-9841
Y-mAbs Therapeutics, Inc. (Issuer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address RUNGSTED STRANDVEJ 113 RUNGSTED KYST G7 2960
Business Address
Wedell-Wedellsborg Johan (Reporting) CIK: 0001753185 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38650 | Film No.: 221091063